The PAX5-JAK2 Translocation Acts as Dual-Hit Mutation That Promotes Aggressive B Cell Leukemia via Nuclear STAT5 Activation

Researchers revealed Pax5-Jak2 as an important nuclear driver of leukemogenesis by maintaining phosphorylated STAT5 levels in the nucleus.